Randomised controlled trial into the role of ramipril in fibrosis reduction in rheumatic heart disease: the RamiRHeD trial protocol
Guardado en:
Autores principales: | Ade Meidian Ambari, Budhi Setianto, Anwar Santoso, Basuni Radi, Bambang Dwiputra, Eliana Susilowati, Fadilla Tulrahmi, Annemiek Wind, Pieter Doevendans |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d448916a9ebd4d70bbae14a1bbd5a763 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prevention and intervention studies with telmisartan, ramipril and their combination in different rat stroke models.
por: Christa Thoene-Reineke, et al.
Publicado: (2011) -
STRESS DEGRADATION STUDIES OF RAMIPRIL BY A VALIDATED STABILITY-INDICATING LIQUID CHROMATOGRAPHIC METHOD
por: DE DIEGO,M, et al.
Publicado: (2010) -
A STABILITY INDICATING HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF VALSARTAN AND RAMIPRIL IN BINARY COMBINATION
por: LAKSHMI,K. S, et al.
Publicado: (2010) -
Self-nanoemulsifying ramipril tablets: a novel delivery system for the enhancement of drug dissolution and stability
por: Alhasani KF, et al.
Publicado: (2019) -
Clinical efficacy of losartan and ramipril in male patients with hypertension depending on age, uricemia level, and hypertension type
por: V.P. Ivanov, et al.
Publicado: (2016)